4-Methylmorpholine → HCID 86748618, compound

HRID 1654409Notes

Reaction equation

HRID 1654409 reaction equation
[C:1]([O:5][C:6]([N:8]1[CH2:13][CH2:12][CH2:11][C@@H:10]([CH2:14][NH:15][C:16]([CH2:18][C@H:19]([NH:30][S:31]([C:34]2[CH:43]=[CH:42][C:41]3[C:36](=[CH:37][CH:38]=[CH:39][CH:40]=3)[CH:35]=2)(=[O:33])=[O:32])[C:20]([N:22]([CH2:26][C:27]([OH:29])=O)[CH:23]2[CH2:25][CH2:24]2)=[O:21])=[O:17])[CH2:9]1)=[O:7])([CH3:4])([CH3:3])[CH3:2].Cl.[CH3:45][O:46][NH2:47].CN1CCOCC1.F[P-](F)(F)(F)(F)F.N1(O[P+](N(C)C)(N(C)C)N(C)C)C2C=CC=CC=2N=N1>C(Cl)Cl.C(OCC)(=O)C>[CH:23]1([N:22]([CH2:26][C:27](=[O:29])[NH:47][O:46][CH3:45])[C:20]([C@@H:19]([NH:30][S:31]([C:34]2[CH:43]=[CH:42][C:41]3[C:36](=[CH:37][CH:38]=[CH:39][CH:40]=3)[CH:35]=2)(=[O:33])=[O:32])[CH2:18][C:16]([NH:15][CH2:14][C@@H:10]2[CH2:11][CH2:12][CH2:13][N:8]([C:6]([O:5][C:1]([CH3:3])([CH3:2])[CH3:4])=[O:7])[CH2:9]2)=[O:17])=[O:21])[CH2:24][CH2:25]1

Participants

7

Procedure

500 mg of [[(S)-3-[(S)-1-tert-butoxycarbonyl-piperidin-3-ylmethylcarbamoyl]-2-(naphthalen-2-sulfonylamino)-propionyl]-cyclopropyl-amino]-acetic acid are stirred at room temperature for 20 hours in 10 ml of methylene chloride together with 71 mg of O-methylhydroxylamine hydrochloride, 0.28 ml of N-methylmorpholine and 376 mg of BOP. The mixture is taken up in ethyl acetate and washed with 1N hydrochloric acid and then with water. After drying and evaporation the product is purified over silica gel with ethyl acetate/methanol (9:1). There are obtained 282 mg of tert-butyl (S)-3-[(S)-3-([cyclopropyl-methoxycarbamoylmethylcarbamoyl)]-3-(naphthalen-2-ylsulfonylamino)-propionylaminomethyl]-piperidine-1-carboxylate, MS (ISP): 646.6 (M+H).

Workup

  1. washwashed with 1N hydrochloric acid
  2. customAfter drying
  3. customevaporation the product
  4. customis purified over silica gel with ethyl acetate/methanol (9:1)

Sources & evidence

ORD record
ord-9967627b71fd4a32812039b0e6e2fee2
Source dataset
uspto-grants-1995_04
Patent number
US05405854

Reaction notes

Loading…